Press Releases - 2021
FOR IMMEDIATE RELEASE
CERI Founder Cancer Researcher Calls for Support for its New Lab
A new laboratory, for and by the people!
CERI Founder Cancer Researcher Calls for Support for its New Lab
A new laboratory, for and by the people!
CAMBRIDGE, MASSACHUSETTS,USA– September 24, 2021 – On World Cancer Research Day, Cancer Education and Research Institute® (CERI), acknowledges how far cancer research has come and thanks all cancer researchers worldwide who have contributed to the development of many live-saving treatments.
"I know too well what it means to work days-and-nights in the laboratory to develop treatments for cancer patients," said CEO, Founder, and Cancer Lead, a geneticist and cancer immunotherapy specialist, cancer researcher of 21 years. "May it be gene therapy or cellular therapy (stem cells or CAR-T cells), cancer research requires in-depth knowledge, hard work, patience, persistence, dedication, and love for science. If otherwise, none of the treatments developed in the laboratory would have made it all the way to patients' bedside."
The story behind what Dr. Sahin led to build CERI can be found CERI's website: https://canceredinstitute.org/about-the-founder
CERI continues with passion and dedication to develop treatments for cancer patients through innovative research. To accomplish this, CERI asks the public to join its efforts to build its independent cancer research laboratory - for, and by the public!
Monetary donations can be made here: https://canceredinstitute.org/donate
"I know too well what it means to work days-and-nights in the laboratory to develop treatments for cancer patients," said CEO, Founder, and Cancer Lead, a geneticist and cancer immunotherapy specialist, cancer researcher of 21 years. "May it be gene therapy or cellular therapy (stem cells or CAR-T cells), cancer research requires in-depth knowledge, hard work, patience, persistence, dedication, and love for science. If otherwise, none of the treatments developed in the laboratory would have made it all the way to patients' bedside."
The story behind what Dr. Sahin led to build CERI can be found CERI's website: https://canceredinstitute.org/about-the-founder
CERI continues with passion and dedication to develop treatments for cancer patients through innovative research. To accomplish this, CERI asks the public to join its efforts to build its independent cancer research laboratory - for, and by the public!
Monetary donations can be made here: https://canceredinstitute.org/donate
###
About Cancer Education and Research Institute (CERI)
Cancer Education and Research Institute® (CERI) (canceredinstitute.org), is the first and only simplified, multi-language 501(c)(3) global non-profit organization. Its mission is to 1) make cancer and cancer research understandable for everyone; 2) bridge the gap between cancer professionals and cancer patients; 3) provide cancer research scholarships for promising high school students worldwide, career guidance, and mentorship; and 4) conduct in-house innovative cancer research and directly translate it to the public. CERI is the United Nations, UNIATF Award 2019 recipient.
Media Inquiries
Reporters may contact
Ayguen Sahin, M.Sc., Ph.D.
CEO, Founder, and Cancer Lead
Cancer Education and Research Institute (CERI)
for more information, or to schedule interviews.
Contact
Reporters may contact
Ayguen Sahin, M.Sc., Ph.D.
CEO, Founder, and Cancer Lead
Cancer Education and Research Institute (CERI)
for more information, or to schedule interviews.
Contact
#worldcancerresearchday #cancerresearch #laboratory #funding #science #cancer #health #canceredinstitute
Media Resources
CERI Media Kit - 2021
Download the CERI Media Kit
| ceri_media_kit.pdf |
Annual Reports and Media Kit (2013-2018)
Cancer Education and Research Institute (CERI)®'s Annual Reports and Media Kit include our 5-year (2013-2018) progress and achievements, fact sheets and demographics, information about our programs, and sponsorship opportunities.
To read our Annual Reports and Media Kit click here.
To read our Annual Reports and Media Kit click here.
